Pulse Biosciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 17.5% | – | – | – | 50.0% | 34.0% | – | 324.4% | 196.6% | 92.3% | 62.9% | 121.6% | |
| – | 82.5% | – | – | – | 50.0% | -34.0% | – | -224.4% | -96.6% | 7.7% | 37.1% | -21.6% | |
| – | 448.2% | – | – | – | 640.7% | 1,239.5% | – | 13,247.7% | 4,139.0% | 3,139.7% | 3,911.5% | 4,378.6% | |
| – | 272.1% | – | – | – | 576.9% | 929.2% | – | 10,210.5% | 6,029.5% | 1,643.6% | 1,948.6% | 3,354.2% | |
| – | 720.3% | – | – | – | 1,217.6% | 2,168.8% | – | 23,458.1% | 6,817.4% | 4,783.3% | 5,860.1% | 6,986.2% | |
| – | -720.3% | – | – | – | -1,217.6% | -2,168.8% | – | -23,682.6% | -6,914.0% | -4,775.6% | -5,823.0% | -7,007.8% | |
| – | 35.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -685.8% | – | – | – | -1,165.0% | -2,018.6% | – | -22,540.7% | -6,603.4% | -4,633.7% | -5,681.3% | -6,755.8% | |
| – | 7.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -685.8% | – | – | – | -1,165.0% | -2,018.6% | – | -22,540.7% | -6,603.4% | -4,633.7% | -5,681.3% | -6,755.8% | |
| – | -668.3% | – | – | – | -1,147.7% | -1,984.6% | – | -22,243.0% | -6,505.3% | -4,712.0% | -5,681.3% | -6,738.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.